Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of High Risk for OSA in Prognosis and Treatment Outcomes of Lung Cancer

NCT04003961 is registered in ClinicalTrials.gov with Atatürk Chest Diseases and Chest Surgery Training and Research Hospital as lead sponsor.

NCT NCT04003961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04003961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of High Risk for OSA in Prognosis and Treatment Outcomes of Lung Cancer
Lead sponsor
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2019
Completion date
December 31, 2021
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, obstructive sleep apnea